This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jul;18(7):719-720.

doi: 10.1016/S1473-3099(18)30342-6.

Chronic Chagas disease: therapeutic protocols and efficacy endpoints

Reggiani Vilela Gonçalves, Rômulo Dias Novaes

PMID: 29976524
DOI: 10.1016/S1473-3099(18)30342-6

Comment

Chronic Chagas disease: therapeutic protocols and efficacy endpoints

Reggiani Vilela Gonçalves et al. Lancet Infect Dis. 2018 Jul.

. 2018 Jul;18(7):719-720.

doi: 10.1016/S1473-3099(18)30342-6.

Authors

Reggiani Vilela Gonçalves, Rômulo Dias Novaes

PMID: 29976524
DOI: 10.1016/S1473-3099(18)30342-6

No abstract available

PubMed Disclaimer

Comment on

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
Torrico F, Gascon J, Ortiz L, Alonso-Vega C, Pinazo MJ, Schijman A, Almeida IC, Alves F, Strub-Wourgaft N, Ribeiro I; E1224 Study Group. Torrico F, et al. Lancet Infect Dis. 2018 Apr;18(4):419-430. doi: 10.1016/S1473-3099(17)30538-8. Epub 2018 Jan 16. Lancet Infect Dis. 2018. PMID: 29352704 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information